Materials and methods for inhibiting cancer cell invasion
AssigneeLicentia Ltd.
InventorsKari Alitalo, Kaisa Lehti, Jorma Keski-Oja, Annamari Alitalo
Life of this patent
Estimating the term…
Loading patent…
AssigneeLicentia Ltd.
InventorsKari Alitalo, Kaisa Lehti, Jorma Keski-Oja, Annamari Alitalo
Estimating the term…
The invention provides an isolated antibody or antibody fragment thereof that binds an extracellular epitope of a fibroblast growth factor receptor-4 (FGFR4) that is expressed by mammalian cells and inhibits cancer cell invasion. Optionally, the antibody or fragment thereof binds an epitope of FGFR4 that is bound by monoclonal antibody F90-10C5, or comprises complementarity determining regions identical to those of monoclonal antibody F90-10C5. Also provided are methods of using the antibody or fragment thereof to modulate invasion, ingrowth, or metastasis of cancer cells and treat cancer in a subject. The invention additionally provides a method of identifying an antibody or antibody fragment that inhibits invasiveness.
An isolated monoclonal antibody, or fragment thereof, or a polypeptide that comprises a fragment of the antibody;
An isolated monoclonal antibody, or fragment thereof, or a polypeptide that comprises a fragment of the antibody;
An isolated monoclonal antibody, antibody fragment, or polypeptide that comprises a fragment of the antibody, wherein the antibody, fragment, or polypeptide comprises all complementarity determining regions (CDR) of monoclonal antibody F85-6C5 (DSM ACC2966) or monoclonal antibody F90-3B6 (DSM ACC2965), or comprises the variable regions of monoclonal antibody F85-6C5 or F90-3B6, and wherein the antibody, antibody fragment, or polypeptide binds an extracellular epitope of FGFR4 that is expressed by mammalian cells.
A composition comprising an adjuvant and at least one of:
A method of selecting an antibody or antibody fragment, wherein the method comprises:
Dependencies are inferred from the claim text.